Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 4 1

Status

Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 3Pain, Postoperative 3Colorectal Neoplasms 3Gastrointestinal Neoplasms 2Depression 2Colonic Neoplasms 2Anxiety Disorders 2Rectal Neoplasms 1Laparoscopic Colorectal Resection Due to Cancer 1Ileus 1Head and Neck Neoplasms 1Diverticulosis, Colonic 1Diverticulitis, Colonic 1Constipation 1Choledocholithiasis 1Choledochal Cyst 1Cholangitis 1Agnosia 1Acute Pain 1

Interventions

Oxaliplatin 29Fluorouracil 25Leucovorin 20Capecitabine 18Irinotecan 17Surveys and Questionnaires 16Bevacizumab 14Cisplatin 12Blood Specimen Collection 11Drug Therapy 10Standard of Care 9Nivolumab 9Gemcitabine 9Cetuximab 7pembrolizumab 6Specimen Handling 6S 1 (combination) 6Endoscopic Mucosal Resection 6Cyclophosphamide 6atezolizumab 5Sunitinib 5Radiotherapy 5Folfox protocol 5Educational Status 5Docetaxel 5fludarabine 4aldesleukin 4Radiosurgery 4Pemetrexed 4Magnetic Resonance Spectroscopy 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Gastrointestinal Neoplasms × Ketamine × Gastrointestinal × Clear all
NCT06077487 2025-05-21

Ketamine-assisted Therapy for Advanced GI Cancer

University of California, San Francisco

Phase 4 Terminated
1 enrolled 10 charts
Gastrointestinal

Gastrointestinal Neoplasms, Acute Pain

NCT06001372 2025-04-16

TREK

University of Utah

Phase EARLY_PHASE1 Terminated
2 enrolled 9 charts
Gastrointestinal

Anxiety Disorders, Depression, Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡